Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
Then Bergh F, Kümpfel T, Schumann E, Held U, Schwan M, Blazevic M, Wismüller A, Holsboer F, Yassouridis A, Uhr M, Weber F, Daumer M, Trenkwalder C, Auer DP
BMC Neurol 2006, 6:19
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]
|
Java Exception error '80004005'
java.lang.NullPointerException
/search/search.asp, line 3161 |
